Amicrobe Selects Clinical Formulation for Amicidin-α P

Amicrobe Selects Clinical Formulation for Amicidin-α PFC, Supported by Department of Defense for Prolonged Field Care of Injured Warfighters

/PRNewswire/ -- Amicrobe, Inc. develops synthetic biologics with physical and antimicrobial properties, called Amicidins. Today, the Company announced the...

Related Keywords

California , United States , Daniel Huang , Amicrobe Amicidin , Michael Bevilacqua , Us Army Medical Research , M Us Department Of Defense , Infectious Diseases Research Program , Development Command Military Infectious Diseases Research Program , Amicrobe Inc , Technology Enterprise Consortium , Development Command , Surgical Gel , Medical Research , Military Infectious Diseases Research Program , Medical Technology Enterprise Consortium ,